Romain Pacaud

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 3

Top Topics

Breast Cancer Risk

Top Venues

JCO precision oncology

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Erica S Tsang, Mallika S Dhawan, Romain Pacaud, Scott Thomas, Jennifer Grabowsky, Lauren Wilch, Silpa Karipineni, Robin Kate Kelley, Andrew H Ko, Eric Collisson, Jocelyn S Chapman, Stefanie Ueda, Emily K Bergsland, Pamela Munster
Synthetic Lethality Beyond BRCA: A Phase I Study of Rucaparib and Irinotecan in Metastatic Solid Tumors With Homologous Recombination-Deficiency Mutations Beyond BRCA1/2. JCO precision oncology 8 (2024)
Erica S Tsang, Mallika S Dhawan, Romain Pacaud, Scott Thomas, Jennifer Grabowsky, Lauren Wilch, Silpa Karipineni, Robin Kate Kelley, Andrew H Ko, Eric Collisson, Jocelyn S Chapman, Stefanie Ueda, Emily K Bergsland, Pamela Munster
Synthetic Lethality Beyond BRCA: A Phase I Study of Rucaparib and Irinotecan in Metastatic Solid Tumors With Homologous Recombination-Deficiency Mutations Beyond BRCA1/2. JCO precision oncology 8 (2024)
Erica S Tsang, Rahul R Aggarwal, Mallika S Dhawan, Emily K Bergsland, Edwin A Alvarez, Susan Calabrese, Romain Pacaud, Jose Garcia, Delaire Fattah, Scott Thomas, Jennifer Grabowsky, Mark M Moasser, Pamela N Munster
A Phase IB Trial of the PI3K Inhibitor Alpelisib and Weekly Cisplatin in Patients with Solid Tumor Malignancies. Cancer research communications 2 (7) (2022)